Are We Ready for Combination Therapy in Moderate-to-Severe Ulcerative Colitis?

被引:5
作者
Lee, Yeong Yeh [1 ,2 ]
Gangireddy, Venugopalareddy [1 ]
Khurana, Sandeep [1 ]
Rao, Satish S. C. [1 ]
机构
[1] Georgia Regents Univ, Dept Med, Sect Gastroenterol & Hepatol, Augusta, GA 30901 USA
[2] Univ Sains Malaysia, Sch Med Sci, Kubang Kerian, Kelantan, Malaysia
关键词
INFLIXIMAB;
D O I
10.1053/j.gastro.2014.03.053
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:544 / 544
页数:1
相关论文
共 3 条
[1]   A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis [J].
Menter, Alan ;
Feldman, Steven R. ;
Weinstein, Gerald D. ;
Papp, Kim ;
Evans, Robert ;
Guzzo, Cynthia ;
Li, Shu ;
Dooley, Lisa T. ;
Arnold, Cynthia ;
Gottlieb, Alice B. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (01) :31-44
[2]   Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis [J].
Panaccione, Remo ;
Ghosh, Subrata ;
Middleton, Stephen ;
Marquez, Juan R. ;
Scott, Boyd B. ;
Flint, Laurence ;
van Hoogstraten, Hubert J. F. ;
Chen, Annie C. ;
Zheng, Hanzhe ;
Danese, Silvio ;
Rutgeerts, Paul .
GASTROENTEROLOGY, 2014, 146 (02) :392-+
[3]   Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2) [J].
Reich, K. ;
Wozel, G. ;
Zheng, H. ;
van Hoogstraten, H. J. F. ;
Flint, L. ;
Barker, J. .
BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (06) :1325-1334